TransAlgae

About:

Enzymes and vaccines out of engineered algae for oral delivery of household animals.

Website: http://www.transalgae.com/

Top Investors: Gan Shmuel Group

Description:

TransAlgae is a biotech company incorporated in the USA, with a research center located at the Science Park of Rehovot, Israel. TransAlgae develops and cultivates a variety of enhanced algae possessing high value products for the growing animal health markets. TransAlgae’s unique, patent pending technology platform harnesses algae as cell factories for the production of customized or off-the-shelf bio-molecules. The platform enables the development of dried (company owned) algae, engineered to contain enzymes, active molecules, vaccines or other proteins to be orally delivered to target organisms. TransAlgae has successfully transformed algae with various functional proteins. The developments are significantly applicable for the aquaculture and poultry industries. These scientifically tested improvements allow us to meet the demands of diverse markets.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Rehovot, HaMerkaz, Israel

Founded Date:

2010-01-01

Contact Email:

info(AT)transalgae.com

Founders:

Maor Sasson

Number of Employees:

11-50

Last Funding Date:

2021-04-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai